coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    North Liverpool PCN, Liverpool (LAD) · Health Inequalities Profile

    PCN U64639 · NHS Cheshire and Merseyside Integrated Care Board · 21 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    134,022

    Registered population

    61.4% aged 18–64

    17.2%

    Aged 65+

    ICB 19.0% · England 17.9%

    11.4%

    Ethnic minority (non-White)

    3.9% Asian · England 9.6%

    67.0%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~80,771

    Core20 residents (est.)

    Resident basis; registered basis ~93,683 · see page 3

    22,594

    Hypertension register

    +2.40% in 3 yrs · England +5.60%

    1,814

    SMI register

    21.6% of Liverpool (LAD)'s

    4,922

    COPD register

    Reviews +4.93% in 3 yrs

    Forecast to 2030

    24,352

    Hypertension patients, 2030

    +1,758 on today

    67.7%

    QRISK ≥20% on statins, 2030

    +0.06pp over 3 yrs

    4.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    74.0%
    Age-five MMR2 and pre-school boosters lag.

    Age-5 MMR2 is 74.0% (England 82.8%), 13.4 pp below MMR1 (87.4%), and 4-in-1 is 71.6%, which may reflect recall gaps to check locally.

    -1.9%
    Heart failure reviews and statin trends trail.

    From 2023 to 2025, heart failure reviews changed -1.9% (England +8.7%) to 74.4% and QRISK >=20% lipid therapy +0.1% (England +6.2%), warranting recall audits.

    70.0%
    Hypertension blood pressure control matches England.

    Hypertension treatment to target is 70.0% (England 70.3%, ICB 69.1%), rising +6.2% from 2023 to 2025 (England +3.6%) and +7.1% in under-80s.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Children make up 21.4% of the list alongside above-average inclusion health registers

    North Liverpool PCN registers 134,022 patients across its member practices. Children aged 0-17 comprise 21.4% (28,650 patients), above Liverpool (19.8%), the ICB (19.2%), and England (19.6%). Patients aged 65+ account for 17.2% (23,099), exceeding Liverpool (15.6%) but below the ICB (19.0%) and England (17.9%). Projected list growth is 2.0% to 2030, trailing Liverpool (3.0%), the ICB (2.3%), and England (2.3%), though projection methodology remains unverified. Residential Census data shows 88.5% White ethnicity (Liverpool 84.0%, ICB 93.0%, England 81.1%) and an 11.4% ethnic minority share; Census residency does not establish registered-patient ethnicity.

    Age profile

    0–1721.4%
    18–6461.4%
    65+17.2%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White88.5%
    Asian3.9%
    Black3.0%
    Other2.3%
    Mixed2.2%

    Older people · falls rows are Liverpool (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Liverpool LA)3,0352,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.9%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)53.0%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Liverpool LA)1,6521,0219552024/25
    Falls deaths, all ages, per 100,000 (Liverpool LA)27.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation is severe across 19 practices, with 67.0% of patients in Core20 areas

    The PCN has an average IMD decile of 2.5 and 67.0% of registered patients live in Core20 areas, compared with 54.9% in Liverpool, 31.9% in the ICB and 21.0% in England. In 19 of 21 practices, Core20 share exceeds England. Concentration reaches 100.0% at practices including Westminster Medical Centre, while Ellergreen Medical Centre carries the largest volume with 11,427 estimated Core20 patients. Weighted practice share is 69.9% versus the PCN rate of 67.0%, a discrepancy requiring base reconciliation before resource targeting.

    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    1,814

    SMI register

    1.32% recorded prevalence

    987

    Learning disability register

    0.72% recorded prevalence

    43

    Care homes, 1,349 beds

    In the PCN catchment

    10.3%

    Provide unpaid care

    Liverpool (LAD), Census 2021

    The PCN records 1,814 patients on the severe mental illness register (1.3% vs Liverpool 1.4%, ICB 1.1%, England 1.0%) and 987 with learning disabilities (0.7% vs Liverpool 0.6%, ICB 0.6%, England 0.6%). Catchment capacity includes 43 care homes with 1,349 beds, though beds do not establish patient registration. Crude register prevalence does not establish unmet need, though recorded registers and local care home capacity define cohorts for structured annual reviews.

    Severe mental illness: physical health checks

    For patients on severe mental illness registers, 80.1% received a blood pressure check (England 83.4%), 80.6% had BMI recorded (England 82.1%), and 79.2% had alcohol status recorded (England 81.8%). Lower completion could reflect outreach barriers, testable by practice audits.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    22,594

    Hypertension register

    +2.40%

    Register growth, 3 yrs

    Liverpool (LAD) +2.01% · England +5.60%

    +4.48pp

    BP control, under 80

    ≤140/90 · +1.16pp aged 80+

    +1,758

    More patients by 2030

    Forecast 24,352 (17.23%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 16.4% (22,594 patients), above Liverpool (14.0%) and England (15.2%) but below NHS Cheshire and Merseyside Integrated Care Board (16.8%). From 2023 to 2025, register growth was +2.4%, trailing England (+5.6%). Recent blood pressure checks reached 88.5% (England 90.0%), with 70.0% treated to target (England 70.3%). For patients aged 80 and over, 81.6% achieved blood pressure <= 150/90 mmHg (England 81.2%), with 2023 to 2025 growth of +1.4% (England +2.2%). Trailing three-year growth and recent checks could reflect review backlogs, which clinical recall audits would test.

    Lipids and statins

    Patients with QRISK ≥ 20% receiving lipid lowering therapy reached 67.6% (England 63.6%), though 2023 to 2025 growth was +0.1% (England +6.2%). In diabetes, statin treatment for patients aged 40 and over without cardiovascular disease was 71.8% (England 73.2%). Flat lipid therapy growth could reflect initiation gaps to test via recall audits.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026279,086£2.00£1.71£1.86£558,172
    Cardiovascular (all), 2025392,365£3.74£4.37£3.33£1,467,445

    For lipid-regulating drugs in 2026, the PCN prescribed 279,086 items at £2.00 per item (Liverpool £1.82, England £1.86, ICB £1.71), spending £39,072 more than at England's unit cost. Unit cost reflects drug choice rather than efficiency. Reviewing lipid-regulating prescribing choices could align PCN expenditure closer to benchmark unit costs.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +2.79%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.03%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 3.6% (4,922 patients; England 1.9%), with 77.4% reviewed in the last 12 months (England 76.4%). On the 8,555-patient asthma register (prevalence 6.6%, England 6.6%), 64.8% had an annual review (England 65.7%), leaving about 3,000 unreviewed. For asthma patients aged 6-19, second-hand smoke recording reached 73.0% (England 78.8%), while asthma prescribing reached 2,200 items per 1,000 aged 5-19 (England 1,488 rate). Lower review rates alongside high paediatric prescribing could reflect follow-up bottlenecks, which record audits would test.

    Cancer register and children's immunisation

    Cancer register prevalence is 3.6% (4,899 patients; England 3.8%). In Q1 2025/26, 6-in-1 coverage at 12 months was 88.0% (England 91.0%). Across 366 children aged 5, 4-in-1 booster coverage was 71.6% (England 80.9%, below the 95.0% target by 23.4 pp). Age-5 MMR dose 2 was 74.0% (England 82.8%), trailing MMR dose 1 (87.4%) by 13.4 pp. Dose drop-off could reflect pre-school recall timing, testable by child health list audits.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months88.0%

    England 91.0%

    6-in-1 complete primary course at 24 months87.1%

    England 92.2%

    MMR dose 1 at 24 months82.5%

    England 88.3%

    MMR dose 2 at age 574.0%

    England 82.8%

    4-in-1 pre-school booster at age 571.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    In NHS Cheshire and Merseyside ICB in 2022 (wider system data, not PCN level), 55.5% of staged cancers (7,482 of 13,490 staged cases) were diagnosed at stage 1 or 2, rising +2.6 pp from 52.8% in 2013 and remaining 19.5 pp below the 75.0% National ambition by 2028. This represents an ICB gap of about 2,640 extra early diagnoses annually, while 72.8% had a known stage. Locally, North Liverpool PCN records 4,899 cancer patients (3.6% prevalence; England 3.8%). Cervical screening coverage for women aged 25 to 49 is 64.7% (England 66.8%), including 42.6% at Fairfield Medical Centre, 54.0% at Stanley Medical Centre, and 56.5% at Anfield Group Practice.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Liverpool University Hospitals NHS Foundation Trust, 75.5% of patients met the 28-day faster diagnosis standard, 0.5 pp above the 75.0% standard. However, 62-day referral-to-treatment performance reached 73.3% (11.7 pp below the 85.0% standard), and the 31-day combined standard reached 90.5% (5.5 pp below the 96.0% standard). Across NHS Cheshire and Merseyside Integrated Care Board, faster diagnosis reached 77.2% (2.2 pp above standard) and 62-day treatment was 76.2% (8.8 pp below standard). These trust and ICB measures describe wider system performance and do not establish PCN referrals or PCN-level waits.

    Pathways within standard (%)LiverpoolMersey and West LancashireWirralCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)75.4772.3974.7177.2579.32
    31-day treatment (96%)90.5195.4692.5395.7192.50
    62-day referral to treatment (85%)73.2677.9677.6576.2371.16
    Diagnostic waits over 6 weeks (%)LiverpoolMersey and West LancashireWirralEngland
    MRI6.4214.041.5421.40
    CT0.7113.081.559.92
    Echocardiography12.5534.885.0728.48
    Colonoscopy33.1418.0432.8130.83
    Gastroscopy44.9918.1717.7329.02
    All 15 DM01 tests11.5021.175.0223.14
    Community services activityLiverpool residentsCheshire and Merseyside ICB
    Care contacts127,380541,280
    Referrals15,67597,150
    Patients with a contact24,970146,240

    Community services (residents of Liverpool), Jun 2026 (provisional). In provisional community services data for June 2026, adults aged 65 and over accounted for 65.4% of contacts among Liverpool borough residents (83,300 of 127,380 contacts). These borough-level contacts were not captured at PCN level, describing wider system activity rather than PCN primary care delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Moss Way11591.194.0%80.6%95.0%
    Poulter Road10237.489.7%68.6%91.2%
    Derby Lane9869.784.6%72.7%89.3%
    Gillmoss11390.872.6%76.6%88.9%
    Fir Tree1220.057.0%82.9%85.0%
    Bousfield - Dr82100.057.7%65.5%84.4%
    Walton11788.358.5%79.2%82.7%
    Jubilee13451.445.2%62.6%79.1%
    Stoneycroft10148.871.1%69.2%77.6%
    Aintree Park10618.248.1%74.1%76.3%
    Langbank10394.948.6%62.0%76.2%
    Stanley83100.054.1%67.7%72.8%
    Fairfield99100.026.9%78.5%70.5%
    Long Lane12078.938.2%73.2%70.4%
    Westminster96100.037.1%61.8%69.2%
    Anfield9697.442.9%58.1%68.5%
    Kirkdale97100.051.1%54.4%67.8%
    Ellergreen9188.231.4%50.2%66.4%
    Grey Road9183.334.1%69.7%64.8%
    Bousfield -97100.052.1%80.1%64.1%
    Westmoreland GP11535.726.7%69.7%63.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNLiverpool (LAD)AssetPCNLiverpool (LAD)
    Care homes (catchment)43 (1,349 beds)n/aSchools (catchment)218n/a
    Children's centres1426Places of worship98240
    Libraries717Homelessness support (VCS)n/a1
    Primary schools (LA maintained)4691Primary academies720
    Special schools48

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma structured annual review recall

    On the 8,555-patient asthma register, 64.8% had a 12-month review (England 65.7%, Liverpool 64.3%), leaving 3,016 (about 3,000) unreviewed; age 6-19 second-hand smoke recording is 73.0% (England 78.8%). For discussion: practices could run a single-template asthma recall and offer after-school or holiday review slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Age-five MMR2 and booster catch-up

    In Q1 2025/26 across 366 children aged 5, MMR2 is 74.0% (England 82.8%, below the 95.0% target by 21 pp, and 13.4 pp below MMR1 at 87.4%); 4-in-1 is 71.6% (below 95.0% by 23.4 pp). Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Coordinated SMI annual physical checks

    Across 1,814 patients on the SMI register, 12-month blood pressure checks reached 80.1% (England 83.4%, ICB 81.3%), BMI recording 80.6% (England 82.1%), and alcohol recording 79.2% (England 81.8%). For discussion: practices could combine SMI check components into single appointments, audit partial-check coding, and assign outreach leads. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Paediatric access and capacity review (p2)Aged 0-17Medium Term Planning Framework 2026 · Neighbourhood health frameworkPCN
    Core20 outreach and capacity allocation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension case finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Asthma structured annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Age-five MMR2 and booster catch-up (p12)MMR dose 2 coverage at age 5 · MMR dose 1 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Coordinated SMI annual physical checks (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15